Clinical trial
Comparison of Two-Point and Four-Point Cervical Injection Techniques Using Methylene Blue for Sentinel Lymph Node Mapping in Endometrial Cancer
NCT07040657 is registered in ClinicalTrials.gov with Dokuz Eylul University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Two-Point and Four-Point Cervical Injection Techniques Using Methylene Blue for Sentinel Lymph Node Mapping in Endometrial Cancer
- Lead sponsor
- Dokuz Eylul University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 1, 2025
- Completion date
- November 1, 2026
- Enrollment
- 100 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial cancer stage i, endometrial neoplasms, metastasis, sentinel lymph node